Skip to main content
Equibles
BTMD logo

BTMD · biote Corp. · Metrics

Track BTMD — free

Use BTMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.33 -0.04 (-2.57%) At close · Sep 21
Rebalance outlook locked
Market Cap
$48.86M
Shares
35.93M

BTMD metrics

77 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.33
Market cap
$48.86M

Price action

20 metrics
Price change (1W)
+2.3%
Price change (30D)
-13.4%
Price change (3M)
-39.8%
Price change (6M)
-11.1%
Price change (YTD)
-47.7%
Price change (1Y)
-59.6%
Trailing year
Price change (5Y)
-86.0%
52-week high
$3.37
52-week low
$1.30
Change from 52-week high
-59.6%
Change from 52-week low
+4.6%
Annualized volatility
73.8%
Annualized volatility (3M)
98.5%
Beta
1.3
RSI (14D)
38.2
Price vs SMA 50
-24.2%
Price vs SMA 200
-33.5%
Avg volume (3M)
317,516
Relative volume
0.5
Average dollar volume
$569,720

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
35.93M

Valuation

12 metrics
P / E (TTM)
13.6
Trailing earnings · reciprocal yield 7.4%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 375.6%
P / book
—
FCF yield
40.7%
TTM · current market cap
Buyback yield
—
P / FCF
2.5
reciprocal yield 40.7%
P / operating cash flow
2.0
reciprocal yield 49.9%
Earnings yield
7.6%

Historical valuation

8 metrics
P / E historical average (3Y)
11.0×
reciprocal yield 9.1%
P / E historical average (5Y)
11.0×
reciprocal yield 9.1%
EV / revenue historical average (3Y)
1.6×
reciprocal yield 61.9%
EV / revenue historical average (5Y)
1.6×
reciprocal yield 61.9%
EV / EBIT historical average (3Y)
10.3×
reciprocal yield 9.7%
EV / EBIT historical average (5Y)
10.3×
reciprocal yield 9.7%
EV / EBITDA historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / EBITDA historical average (5Y)
9.2×
reciprocal yield 10.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
31.2%
Shareholder yield
2.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
—
Operating margin
8.0%
Trailing 12 months
Net margin
2.0%
Gross profit (TTM)
—
Operating profit (TTM)
$14.75M
Net income (TTM)
$3.73M
Trailing 12 months
Diluted EPS (TTM)
$0.10
FCF margin
10.8%
Effective tax rate
31.0%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.76

Growth

11 metrics
Revenue growth YoY
-9.5%
Year over year
Net income growth YoY
-306.1%
Revenue (TTM)
$183.53M
Trailing 12 months
EPS growth YoY
-330.0%
Shares change YoY
-9.8%
Year over year · fewer shares
Revenue CAGR (3Y)
+5.2%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
3.7%
Debt / equity
—
Current ratio
1.4
EBITDA (TTM)
$18.60M
Free cash flow (TTM)
$19.87M
Quick ratio
0.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$11.17M
Total assets
$101.70M
Total debt
$121.50M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$24.37M
Capital expenditures (TTM)
$4.50M
R&D (TTM)
—
SG&A (TTM)
$111.11M
Stock compensation (TTM)
$8.34M
R&D / revenue
—
Stock compensation / revenue
4.5%

Ownership (13F)

3 metrics
13F filers
71
13F filer change QoQ
-13
Institutional ownership
36.6%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 3.4 days to cover
Days to cover
3.4d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
$202,204
Insider-sentiment score
84 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1819253 CUSIP 090683103 13F (30d) 1 filings 1 filers Visit website Investor relations